Stuart A Grossman

Professor

1981 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Stuart A Grossman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
temozolomide Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Glioma Medicine & Life Sciences
Brain Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1981 2019

Aquaporin-4 Expression Patterns in Glioblastoma Pre-Chemoradiation and at Time of Suspected Progression

Levy, M., Barletta, S., Huang, H., Grossman, S. A., Rodriguez, F. J., Ellsworth, S. G., Dzaye, O. & Holdhoff, M., Feb 7 2019, In : Cancer Investigation. 37, 2, p. 67-72 6 p.

Research output: Contribution to journalArticle

Aquaporin 4
Glioblastoma
Edema
Staining and Labeling
Biopsy

BRAF mutations and the utility of RAF and MEK inhibitors in primary brain tumors

Schreck, K., Grossman, S. A. & Pratilas, C., Sep 1 2019, In : Cancers. 11, 9, 1262.

Research output: Contribution to journalReview article

Open Access
Mitogen-Activated Protein Kinase Kinases
Brain Neoplasms
Mutation
Glioma
Clinical Trials

Phase II study of iniparib with concurrent chemoradiation in patients with newly diagnosed glioblastoma

Adult Brain Tumor Consortium, Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 73-79 7 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Radiotherapy
Survival
Confidence Intervals

Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas

Ho, W. J., Yarchoan, M., Hopkins, A., Mehra, R., Grossman, S. A. & Kang, H., Aug 31 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 84.

Research output: Contribution to journalArticle

Lymphocyte Count
Immunotherapy
Cohort Studies
Carcinoma, squamous cell of head and neck
Therapeutics

Concurrent BRAF/MEK inhibitors in BRAF V600-Mutant high-grade primary brain tumors

Schreck, K. C., Guajardo, A., Lin, D., Eberhart, C. G. & Grossman, S. A., Apr 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 4, p. 343-347 5 p.

Research output: Contribution to journalComment/debate

Mitogen-Activated Protein Kinase Kinases
Brain Neoplasms
temozolomide
Mutation
Therapeutics